Pharming Group N.V. Receivables

Pharming Group N.V. (PHARM.AS) currently reports a receivables of $57M as of June 2026. That compares with $53M in the prior-year period — up 6.9% year over year. Use the charts on this page to explore Pharming Group N.V.'s receivables history and peer comparisons.

Pharming Group N.V.'s receivables increased from $53M to $57M — a 6.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pharming Group N.V. reported $57M in receivables as of June 2026. That compares with $53M in the prior-year period — up 6.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $57M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pharming Group N.V., and consider following PHARM.AS for alerts when major investors trade the stock.

Pharming Group N.V. is classified in the Healthcare sector. On receivables, it currently shows $57M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHARM.AS with unrelated industries.